Bluebird Bio Competitors and Similar CompaniesClear all
Bluebird Bio's competitors and similar companies include Tanvex BioPharma, H3 Biomedicine, Ionis Pharmaceuticals and Genprex.
 Tanvex BioPharma Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs. |  Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics. | ||||
Founding Date | Founding Date 1992 | Founding Date 2013 | Founding Date 2011 | Founding Date 1989 | Founding Date 2009 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Somerville, US HQ | Locations Taipei, TW HQ New Taipei, TW Irvine, US San Diego, US San Diego, US | Locations Cambridge, US HQ | Locations Carlsbad, US HQ | Locations West Lake Hills, US HQ Austin, US |
Employees | Employees 32338% decrease | Employees 13827% decrease | Employees 378% decrease | Employees 92716% increase | Employees 2865% increase |
Valuation ($) | Valuation ($) 95.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 6.3 b | Valuation ($) 6.3 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $83.8m (FY, 2024) | Revenue (est.) NT$34.7m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $705.1m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods $89.4m (FY, 2024) | Cost of goods NT$26.4m (FY, 2024) | Cost of goods N/A | Cost of goods $11.2m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit ($5.6m) (FY, 2024) | Gross profit NT$8.7m (FY, 2024) | Gross profit N/A | Gross profit $693.9m (FY, 2024) | Gross profit N/A |
Net income | Net income ($240.7m) (FY, 2024) | Net income (NT$1.4b) (FY, 2024) | Net income N/A | Net income ($453.9m) (FY, 2024) | Net income ($21.1m) (FY, 2024) |
Operating ⚠ | |||||
Trademarks (US) | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) 3 (Jul, 2021) | Trademarks (US) 6 (FY, 2023) | Trademarks (US) N/A |
Funding | |||||
Total funding raised | Total funding raised $ 409m | Total funding raised $ 346.9m | Total funding raised $ 200m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Tanvex BioPharma
HQ
Taipei, TW
Employees
138↓ 27% decrease
Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.
View company
H3 Biomedicine
HQ
Cambridge, US
H3 Biomedicine is a biopharmaceutical company that specializes in cancer genomics.
View companyIonis Pharmaceuticals
HQ
Carlsbad, US
Employees
927↑ 16% increase
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
View company
Genprex
HQ
West Lake Hills, US
Employees
28
Genprex is a gene therapy company developing treatments for cancer and diabetes.
View company